INX IMCD N.V.

Shareholders IMCD N.V. adopt all resolutions at AGM

Shareholders IMCD N.V. adopt all resolutions at AGM

Rotterdam, The Netherlands (25 April 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces that all resolutions proposed to the shareholders at the Annual General Meeting of Shareholders (AGM) held today were adopted.

The resolutions included the adoption of the financial statements for the year 2024 and the proposal of a cash dividend of EUR 2.15 per share.

The dividend calendar is as follows:

  • 29 April 2025                Ex-dividend date
  • 30 April 2025                Dividend record date
  • 6 May 2025                  Dividend payment date



The 2024 Remuneration Report received support from shareholders with 97.78% of votes casted in favor of the report.

Further details of the AGM, including all voting results, are available in the Investors Relations’ section of the Company’s website .

- xxx-

About IMCD

IMCD, based in Rotterdam, The Netherlands, is a leading global partner for the distribution and formulation of speciality chemicals and ingredients. IMCD is an expert solutions provider and adds sustainable value to the supply chain. Every day professionals focus on providing the best service through commercial and operational excellence. The company is mindful of the role they play in creating a better planet for all and formulates with consciousness and executes with care, to address business challenges of tomorrow, in partnership and transparency.

In 2024, with over 5,100 employees, IMCD realised revenues of EUR 4,728 million. IMCD N.V.’s shares are traded at Euronext Amsterdam (symbol: IMCD) and included in the Dutch ESG AEX index, as one of 25 companies within the AEX and AMX indices demonstrating best ESG practices.

For further information, please visit    

Media contact

Muriel Werlé

Corporate Communications Director

4

Investor relations contact

Tosca Holtland

Head of Investor Relations

3

Attachment



EN
25/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMCD N.V.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ageas: 1H leads to increase in 2025 net result guidance, but also FCF. IMCD: Material acquisition in Italy. Kendrion: Unlocking value, sells Chinese business at high multiple. Retail Estates: Limited impact of Leen Bakker judicial reorganization

Guy Sips ... (+6)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi

Morning Notes : AGS BB, AGFB BB, IVA FP, RET BB, TWEKA NA, VAN BB, NXF...

: AGS BB, AGFB BB, IVA FP, RET BB, TWEKA NA, VAN BB, NXFIL NA, IMCD NA

 PRESS RELEASE

IMCD to acquire Tillmanns to further strengthen its presence in Italy

IMCD to acquire Tillmanns to further strengthen its presence in Italy Rotterdam, The Netherlands (27 August 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Tillmanns S.p.A. (“Tillmanns”). Founded in 1940 and headquartered in Milan, Italy, Tillmanns is a well-established distributor of specialty chemicals, acting as a key partner for global suppliers and a broad base of customers. With operations strongly anchored in Italy, the company oper...

IMCD NV: 1 director

A director at IMCD NV bought 1,000 shares at 99.100EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch